Kailera Therapeutics (KLRA) IPO deck
Develops injectable and oral GLP-1–based therapies for obesity treatment across multiple clinical stages.
Develops injectable and oral GLP-1–based therapies for obesity treatment across multiple clinical stages.
%20IPO%20deck){kind=link}